BCDA
BioCardia Inc.
Halal Rating :
Last Price
$2.18
Last updated:
Market Cap
-
7D Change
-3.11%
1 Year Change
390.33%
Company Overview
Industries
Exchange
Next Earnings Date
BioCardia, Inc. is a clinical-stage biotherapeutics company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. The company's lead therapeutic candidates include CardiAMP Cell Therapy for heart failure and chronic myocardial ischemia, and CardiALLO Cell Therapy.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $3000.0 | $1.65m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $55000.0 | $2.33m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate BioCardia Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.